CSPC Innovation Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 287.54% vs 17.69% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 1,394.30% vs 56.57% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,575.60",
          "val2": "664.60",
          "chgp": "287.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,751.50",
          "val2": "-53.30",
          "chgp": "3,386.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10.20",
          "val2": "14.10",
          "chgp": "-27.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.40",
          "val2": "1.60",
          "chgp": "175.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,681.30",
          "val2": "-129.90",
          "chgp": "1,394.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "656.40%",
          "val2": "-171.60%",
          "chgp": "82.80%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 9.17% vs -21.91% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -100.96% vs -341.21% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,147.40",
          "val2": "1,967.10",
          "chgp": "9.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-402.60",
          "val2": "-59.50",
          "chgp": "-576.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "22.50",
          "val2": "6.80",
          "chgp": "230.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.10",
          "val2": "0.50",
          "chgp": "1,320.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-609.30",
          "val2": "-303.20",
          "chgp": "-100.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-291.40%",
          "val2": "-140.70%",
          "chgp": "-15.07%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

2,575.60

664.60

287.54%

Operating Profit (PBDIT) excl Other Income

1,751.50

-53.30

3,386.12%

Interest

10.20

14.10

-27.66%

Exceptional Items

4.40

1.60

175.00%

Consolidate Net Profit

1,681.30

-129.90

1,394.30%

Operating Profit Margin (Excl OI)

656.40%

-171.60%

82.80%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 287.54% vs 17.69% in Mar 2026

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 1,394.30% vs 56.57% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

2,147.40

1,967.10

9.17%

Operating Profit (PBDIT) excl Other Income

-402.60

-59.50

-576.64%

Interest

22.50

6.80

230.88%

Exceptional Items

7.10

0.50

1,320.00%

Consolidate Net Profit

-609.30

-303.20

-100.96%

Operating Profit Margin (Excl OI)

-291.40%

-140.70%

-15.07%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 9.17% vs -21.91% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -100.96% vs -341.21% in Dec 2024

All Annual Results